Display Settings:

Format

Send to:

Choose Destination
Bioorg Med Chem Lett. 2006 Mar 1;16(5):1320-3. Epub 2005 Dec 5.

SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors.

Author information

  • 1AstraZeneca, Mereside, Alderley Park, Macclesfield, Cheshire SK10 4TG,UK. Nicola.Heron@astrazeneca.com

Abstract

A novel series of 5-aminopyrimidinyl quinazolines has been developed from anilino-quinazoline 1, which was identified in a high throughput screen for Aurora A. Introduction of the pyrimidine ring and optimisation of the substituents both on this ring and at the C7 position of the quinazoline led to the discovery of compounds that are highly specific Aurora kinase inhibitors. Co-crystallisation of one of these inhibitors with a fragment of Aurora A shows the importance of the benzamido group in achieving selectivity.

PMID:
16337122
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk